Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
URL: http://antibodyregistry.org/AB_11173028
Proper Citation: GeneTex Cat# GTX36664, RRID:AB_11173028
Target Antigen: Herpes simplex virus type 2 gE antibody [0111]
Host Organism: mouse
Clonality: monoclonal
Comments: Discontinued; manufacturer recommendations: Western Blot; ELISA; Immunocytochemistry; Immunofluorescence; Immunohistochemistry; Recommended Starting Dilutions: For ICC/IF: Use at 1:10-1:50; For WB: Use at 1:10-1:50; For IHC: Use at 1:10-1:50; For ELISA: Use at 1:20-1:200; Not yet tested in other applications. Optimal dilutions should be determined experimentally by the researcher., The usefulness of this product in other applications has not been determined.
Expand AllWe found {{ ctrl2.mentions.all_count }} mentions in open access literature.
We have not found any literature mentions for this resource.
We are searching literature mentions for this resource.
Most recent articles:
{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})
A list of researchers who have used the resource and an author search tool
A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.
No rating or validation information has been found for Herpes simplex virus, type 2 gE antibody [0111].
Discontinued
Discontinued at GeneTex
Source: Antibody Registry
dkNET can assist you in preparing authentication plans for antibodies to comply with the NIH Submission Policy. The information can be used while planning your experiments or submitting grant applications. The authentication plan for antibodies is based on methods suggested in "A proposal for validation of antibodies" (Uhlen M et. al., 2016), the guideline published in the Journal of Comparative Neurology (Saper C, 2005)(2), and the example " Authentication of of Key Biological and/or Chemical Resources "(Bandrowski A). For best practices for authenticating antibodies, check our Authentication Reports services.